Bile acids algorithm
Use results to:
- Assess liver function
- Identify occult liver disease
- Evaluate for vascular anomalies
- Monitor patients on hepatotoxic medication
Clinical signs and diagnostic findings consistent with hepatobiliary disease
Clinical signs
Breed predilection
Poor growth in young animal
Poor recovery from anaesthesia/sedation
Neurologic signs
History of hepatotoxic medication
Weight loss
Anorexia/vomiting/diarrhoea
Ascites
Icterus*
CBC
Decreased and/or low normal MCV
Urinalysis
Ammonium biurate crystals
Bilirubin (feline)
Chemistry panel
Decreased or low normal:
- UREA
- Albumin
- Glucose
- Cholesterol
Increased:
- ALT, AST, GGT, ALP (persistent elevation or ≥ 3x upper end of reference interval)
- Total bilirubin*
*If patient is icteric or if bilirubin is increased, rule out prehepatic causes and proceed without bile acids testing (see below).
2 or more of the above clinical indicators?
Consider extrahepatic diseases where appropriate; perform pre- and postprandial bile acids*
Normal
Canine
Preprandial: 0–14.9 μmol/L
Postprandial: 0–29.9 μmol/L
Feline
Preprandial: 0–6.9 μmol/L
Postprandial: 0–14.9 μmol/L
Does not rule out the presence of hepatobiliary disease
Mild elevation
Canine
Pre- or postprandial: 30.0–40.0 μmol/L
Feline
Pre- or postprandial: 15.0–30.0 μmol/L
Can be seen with both extrahepatic and hepatobiliary disease
Moderate to severe elevation
Canine
Pre- or postprandial: >40.0 μmol/L
Feline
Pre- or postprandial: >30.0 μmol/L
Consistent with hepatic dysfunction and/or cholestatic liver disease
Rule out extrahepatic causes
Consider supportive care and reevaluate as appropriate
Continued suspicion of primary hepatobiliary disease?
Investigate for underlying hepatobiliary disease
Increased bile acids and/or hepatic enzymes?
Evaluate for extrahepatic diseases
Possible causes
- Pancreatitis
- Gastrointestinal disease
- Endocrine
- Hyperadrenocorticism
- Hyperthyroidism
- Diabetes mellitus
- Extrahepatic neoplasia
- Hypoperfusion (congestive heart failure, shock)
- Trauma
- Drug induced (ALP/GGT)
- Steroids, phenobarbital
- Muscular disease (ALT/AST)
- Osteolytic disease/bone (ALP)
Consider performing
- Spec cPL Test/Spec fPL Test
- Diagnostic imaging
- Endocrine testing
Investigate underlying hepatobiliary disease
Possible causes
- Inflammation (chronic hepatitis, cholangiohepatitis)
- Infection (leptospirosis, bacterial cholangiohepatitis)
- Toxicity (NSAID, phenobarbital, sago palm)
- Vascular anomaly (portosystemic shunt, microvascular dysplasia)
- Neoplasia (primary or metastatic)
- Cholestatic liver disease
- Lipidosis
- Vacuolar hepatopathy
- Cirrhosis
- Biliary disease
- Mucocoele
- Cholelith
- Biliary neoplasia
- Cholecystitis
- Breed-related increase (Maltese)
Consider performing
- Coagulation profile (PT/aPTT)
- Ammonia
- Diagnostic imaging
- Cytology
- Biopsy
- Special testing as indicated (liver copper concentrations, liver culture)
- Infectious disease testing